Agency,Autonomy and Euthanasia

Abstract

Agency is the human capacity to freely choose one’s thoughts, motivations and actions without undue internal or external influences; it is distinguished from decisional capacity. Four well-known conditions that can deeply affect agency are depression, demoralization, existential distress, and family dysfunction. The study reviews how they may diminish agency in persons whose circumstances may lead them to consider or request euthanasia or assisted suicide. Since agency has been a relatively neglected dimension of autonomous choice at the end of life, it is argued that to respect the autonomy of individuals, it is essential to establish their agency.

Get full access to this article

View all access options for this article.

References

R. J.

Wilson

, “Is Respect for Autonomy Defensible?” Journal of Medical Ethics 33, no. 6 (2007): 353-356.

van Veen

et al., “Euthanasia of Dutch Patients with Psychiatric Disorders between 2015 and 2017,” Journal of Ethics in Mental Heath (Open) 10 (2018): 1-15.

Government of Canada, “Medical Assistance in Dying,” End-of-life care, 2020, available at <https://www.canada.ca/en/health-canada/services/medical-assistance-dying.html#a2> (last visited August 12, 2020)

Patients Rights Council, “Assisted Suicide Laws in the United States,” 2017, available at <http://www.patientsrightscouncil.org/site/assisted-suicide-state-laws/> (last visited August 13, 2020).

State of Oregon, “Death with Dignity Act,” Chapter 127, Oregon Health 2019, available at <https://www.oregon.gov/oha/ph/ProviderPartnerResources/EvaluationResearch/DeathwithDignityAct/Pages/ors.aspx> (last visited August 13, 2020).

Oregon Death with Dignity Act: 2019 Data Summary, “Year 22 Annual Report,” Table 1, p. 11. (State of Oregon, Oregon Health, 2020).

Supra note 5.

Swiss Academy of Medical Sciences, “Assessment of Capacity in Medical Practice,” in Medical Ethics Guidelines (Gremper AG, Basel, 2019).

Radoilska

, “Depression, Decisional Capacity and Personal Autonomy,” in The Oxford Handbook of Philosophy and Psychiatry,

K. W. M.

Fulford ,

Davis ,

Graham ,

Sadler ,

Stanghellini , and

Thornton eds. (Oxford: Oxford University Press, 2013), Chapter 67, doi: 10.1093/oxfordhb/9780199579563.013.0067.

10.

Bandura

, “Human Action in Social Cognitive Theory,” American Psychologist 44, no. 9 (1989): 1175-1189.

11.

Bandura

, Social Foundations of Thought and Action (Englewood Cliffs, NJ: Prentice-Hall, 1986).

12.

Schlosser

, “Agency,” Stanford Encyclopedia of Philosophy, 2019, available at <http://plato.stanford.edu/entries/agency/> (last visited August 13, 2020).

13.

Bandura, supra note 10.

14.

A. S.

Roth

, “Practical Intersubjectivity and Normative Guidance: Brat-man on Shared Agency,” Journal of Social Ontology 1, no. 1 (2015): 39-48.

15.

Shoemaker

, “Caring, identification, and agency,” Ethics 114, no. 1 (2003): 88–118.

16.

Buss

, “Personal Autonomy,” Stanford Encyclopedia of Philosophy, 2014, available at <http://plato.stanford.edu/archives/win2014/entries/personal-autonomy/> (last visited August 13, 2020).

17.

Nickson

, “Capacity and Competence,” Life in the Fastlane, 2018, available at <https://lifeinthefastlane.com/ccc/capacity-and-competence/> (last visited August 13, 2020).

18.

L. C.

Charland

, “Decision-Making Capacity,” Stanford Encyclopedia of Philosophy, 2015 available at <http://plato.stanford.edu/archives/win2014/entries/personal-autonomy/> (last visited August 13, 2020), 1-36, 1.

19.

Charland 2015, supra note 18.

20.

Charland 2015, supra note 18.

21.

Supra note 9.

22.

Boettger

et al., “Assessment of Decisional Capacity: Prevalence of Medical Illness and Psychiatric Comorbidi-ties,” Palliative Support Care 13, no. 5 (2015): 1275-1281.

23.

Bandura, supra note 11.

24.

D. C.

Marson

et al., “Assessing the Competency of Patients with Alzheimer’s Disease under Different Legal Standards. A Prototype Instrument,” Archives of Neurology 52, no. 10 (1995): 949-954.

25.

Grisso

et al., “The MacCAT-T: A Clinical Tool to Assess Patients’ Capacities to Make Treatment Decisions,” Psychiatric Services 48, no. 11 (1997): 1415-1419.

26.

Edelstein

, Hopemont Capacity Assessment Interview Manual and Scoring Guide (Morgantown, WV: West Virginia University, 1999).

27.

D. V.

Jeste

et al., “A New Brief Instrument for Assessing Decisional Capacity for Clinical Research,” Archives of General Psychiatry 64, no. 8 (2007): 966-974.

28.

Buss, supra note 16.

29.

Karlawish

, “Assessment of Decision-Making Capacity in Adults,” UpToDate, 2017, available at <https://www.upto-date.com/contents/assessment-of-decision-making-capacity-in-adults> (last visited August 13, 2020).

30.

Nickson, supra note 17.

31.

Buss, supra note 16.

32.

D. W.

Kissane ,

D. M.

Clarke , and

A. F.

Street , “Demoralization Syndrome: A Relevant Psychiatric Diagnosis for Palliative Care,” Journal of Palliative Care 17, no. 1 (2001): 12-21.

33.

Robinson

et al., “A Systematic Review of the Demoralization Syndrome in Individuals with Progressive Disease and Cancer: A Decade of Research,” Journal of Pain and Symptom Management 49, no. 3 (2015): 595-610.

34.

Galiana

et al., “The Short Demoraliation Scale (SDS): A New Tool to Appraise Demoralization in Palliative Care,” Palliative Supportive Care 15, no. 5 (2017): 516-523.

35.

Rodin

et al., “Managing Cancer and Living Meaningfully (CALM): A Randomized Controlled Trial of a Psychological Intervention for Patients with Advanced Cancer,” Journal of Clinical Oncology 36, no. 23 (2018): 2422-2432.

36.

Grassi and

M. G.

Nanni , “Demoralization Syndrome: New Insights in Psychosocial Cancer Care,” Cancer 112, no. 14 (2016): 2130-2133.

37.

Robinson, supra note 33.

38.

World Health Organisation, Depression and other Common Mental Disorders, (Geneva: WHO Document Productions Services, 2017 Licence: CC BY-NC-SA 3.0 IGO), 7.

39.

National Health Service, “Diagnosis of Clinical Depression,” 2016, available at <https://www.nhs.uk/conditions/clinical-depression/diagnosis/> (last visited August 13, 2020).

40.

J. E.

Anderson

et al., “Depression in Primary Care: Tools for Screening, Diagnosis and Measuring Response to Treatment,” British Clinical Medical Journal 44, no. 8 (2002): 415-419.

41.

National Institute of Mental Health, “Depression,” 2018, available at <https://www.nimh.nih.gov/health/topics/depression/index.shtml#part_145399> (last visited August 13, 2020).

42.

Supra note 38.

43.

Supra note 38.

44.

D. L.

Rosenstein

, “Depression in End-of-Life Care for Patients with Cancer,” Dialogues in Clinical Neuroscience 13, no. 1 (2011): 101-108.

45.

E. A. P.

Haigh

et al., “Depression Among Older Adults: A 20-Year Update on Five Common Myths and Misconceptions,” American Journal of Geriatric Psychiatry 26 (2018): 107-122.

46.

D. W.

Kissane

, “The Relief of Existential Suffering,” Archives of Internal Medicine 172, no. 19 (2012): 1501-1505.

47.

Ettema

et al., “Existenial Loneliness and End-of-Life Care: A Systematic Review,” Theoretical Medical Bioethics 31, no. 2 (2010): 141-169.

48.

Id.

49.

Morita

et al., “Existential Concerns of Terminally Ill Cancer Patients Receiving Specialized Palliative Care in Japan,” Support Care Cancer 12, no. 2 (2004): 137-140.

50.

H. M.

Chochinov

et al., “Dignity in the Terminally Ill: revisited,” Palliative Medicine 9 (2006): 666-672.

51.

Henoch and

Danielson , “Existential Concerns among Patients with Cancer and Interventions to Meet Them: An Integrative Literature Review,” Psychooncology 18, no. 3 (2009): 225-236.

52.

et al., “Preliminary Psychometrics of the Existential Distress Scale in Patients with Advanced Cancer,” European Journal of Cancer Care 26 (2017): e12597.

53.

Kelly ,

McClement , and

H. M.

Chochinov , “Measurement of Psychological Distress in Palliative Care,” Palliative Medicine 20 (2006): 779-789.

54.

Vehling and

Phillip , “Existential Distress and Meaning-Focused Interventions in Cancer Survivorship,” Current Opinion in Supportive and Palliative Care 12, no. 1 (2018): 46-51.

55.

World Health Organisation, World Report on Ageing and Health (Geneva: WHO Press, 2015), 12.

56.

Poudel-Tandukar

et al., “Differences in Suicide Risk According to Living Arrangements in Japanese Men and Women — The Japan Public Health Center-Based (JPHC) Prospective Study,” Journal of Affective Disorders 131, nos. 1-3 (2011): 113–119.

57.

Le May and

Wilson , “Treatment of Existential Distress in Life Threatening Illness: A Review of Manualized Interventions,” Clinical Psychology Review 28 (2008): 472-493.

58.

H. M.

Chochinov

et al., “The Effect of Dignity Therapy on Distress and End-of-Life Experience in Terminally Ill Patients: A Randomised Controlled Trial,” Lancet Oncology 12, no. 8 (2011): 753-762.

59.

Hooley

, “Expressed Emotion and Psychiatric Illness: From Empirical Data to Clinical Practice,” Behavior Therapy 29, no. 4 (1998): 631-646.

60.

J. S.

Rolland

, “The Family with Chronic Physical Disorders. An Integrative Model,” Bereavement Care for Families,

D. W.

Kissane and

Parnes eds., (New York: Routledge, 2014), 30-50.

61.

T. Y. G.

van der Voort ,

P. J. J.

Goossens , and

J. J.

van der Bijl , “Burden Coping and Needs for Support of Caregivers of Patients with a Bipolar Disorder: A Systemic Review,” Journal of Psychiatric and Mental Health Nursing 14, no. 7 (2007): 679-687.

62.

D. W.

Kissane

et al., “Perceptions of Family Functioning and Cancer,” Psycho-Oncology 3, no. 1 (1994): 259-269.

63.

Bowen

, Family Therapy in Clinical Practice (New York: Jason Aronson, 1978).

64.

Kim, supra note 22.

65.

I. D.

Yalom

, The Theory and Practice of Group Psychotherapy, 4th Edition (New York, NY: Basic books, 1995).

66.

Robinson

et al., “A Review of the Construct of Demoralization: History, Definitions, and Future Directions for Palliative Care,” American Journal of Hospice and Palliative Care 33, no. 1 (2016): 93-101.

67.

Kissane, supra note 49;

Robinson

et al., “Refinement and Revalidation of the Demoralization Scale: The DS-II External Validity,” Cancer 122, no. 14 (2016): 2260-2267.

68.

Robinson, supra note 67;

I. D.

Yalom

, The Yalom Reader: Selections From the Work of a Master Therapist and Storyteller (New York, NY: Basic Books, 1998).

69.

Kissane 2001, supra note 32; Kissane 2004, supra note 66.

70.

R. D.

Wetzel

, “Hopelessness, Depression, and Suicide Intent,” Archives of General Psychiatry 33, no. 9 (1976): 1069.

71.

Vehling

et al., “The Association of Demoralization with Mental Disorders and Suicidal Ideation in Patients with Cancer,” Cancer 123, no. 17 (2017): 3394-3401.

72.

Rudnick

, “Depression and Competence to Refuse Psychiatric Treatment,” Journal of Medical Ethics 28, no. 3 (2002): 151–155.

73.

Robinson, supra note 66.

74.

Slaby ,

Paskaleva , and

Stephan , “Enactive Emotion and Impaired Agency in Depression,” Journal of Consciousness Studies 20, no. 7–8 (2013): 33-55.

75.

Grisso, supra note 25.

76.

Radoilska, supra note 9.

77.

Stocker

, “Desiring the Bad: An Essay in Moral Psychology,” Journal of Philosophy 76, no. 12, (1979): 738-753.

78.

Supra note 3.

79.

Supra note 9.

80.

Hobbs and

McLaren , “The Interrelations of Agency, Depression, and Suicidal Ideation Among Older Adults,” Suicide and Life-Threatening Behavior 39, no. 2 (2009) 161-171.

81.

Lo, supra note 52;

Vehling and

D. W.

Kissane , “Existential Distress in Cancer: Alleviating Suffering from Fundamental Loss and Change,” Psycho-Oncology 27, no. 11 (2018): 2525-230.

82.

P. N.

Butow

et al., “Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence,” Journal of Clinical Oncology 35, no. 36 (2017): 4066-4077.

83.

Groff

et al., “Examining the Sustainability of Screening for Distress, The Sixth Vital Sign, In Two Outpatient Oncology Clinics: A Mixed-Methods Study,” Psycho-Oncology 27, no. 1 (2018): 141-147.

84.

Pauley

et al., “Predictors of Caregiver Distress in the Community Setting Using the Home Care version of the Resident Assessment Instrument,” Professional Case Management 23, no. 2 (2018): 60-69.

85.

Byng-Hall

, “Loss and Family Scripts,” in Living Beyond Loss: Death in the Family,

Walsh and

McGoldrick eds., (New York: Norton, 2004).

86.

Sudhinaraset

et al., “Social and Cultural Contexts of Alcohol Use: Influences in a Social–Ecological Framework,” Alcohol Research 38, no. 1 (2016): 35–45.

87.

American Addiction Centers, “Effects of Alcoholism on Families and Close Friends,” 2020, available at <https://www.alcohol.org/faq/problems-associated-with-alcoholism/> (last visited August 13, 2020).

88.

National Organisation for Rare Diseases, “Wernicke-Korsakoff Syndrome,”

Rare Diseases Database

2005, available at <https://rarediseases.org/rare-diseases/wernicke-korsakoff-syndrome/> (last visited August 13, 2020).

89.

Karlawish, supra note 29.

90.

Buss, supra note 16.

91.

Karlawish, supra note 29.

92.

Karlawish, supra note 29.